Join
Live feed
·
PRReleasevia Quantisnow
Albireo Pharma Inc. logo

Albireo Reports Positive Topline Data from Phase 3 Trial of Bylvay® (odevixibat) in Alagille Syndrome

ByQuantisnow·Wall Street's wire, on your screen.
ALBO· Albireo Pharma Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ALBO (Albireo Pharma Inc.) and more on Quantisnow.